Showing results (2111-2120 of 2,339) with videos related to

Sort By:
Pageof 234
Toxicology and Applied Pharmacology|August 19, 2024
High-Throughput Transcriptomics Screen of ToxCast Chemicals in U-2 OS CellsJoseph L Bundy, Logan J Everett, Jesse D Rogers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2012
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancerPaul Nathan, Martin Zweifel, Anwar R Padhani, et al.
Journal of Mammary Gland Biology and Neoplasia|March 11, 2020
Inter-Individual Variation in Response to Estrogen in Human Breast ExplantsKaren A Dunphy, Amye L Black, Amy L Roberts, et al.
Abdominal Radiology (New York)|October 7, 2017
Low kV versus dual-energy virtual monoenergetic CT imaging for proven liver lesions: what are the advantages and trade-offs in conspicuity and image quality? A pilot studyG Jay Hanson, Gregory J Michalak, Robert Childs, et al.
JMIR Research Protocols|April 15, 2026
Building Capacity in Institutional Operational Research in Low-Resource Settings: Protocol for an Implementation Research StudySana Ali, G V S Murthy, Kenneth L Bassett, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 30, 2013
Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assaysBarbara A Wetmore, John F Wambaugh, Stephen S Ferguson, et al.
The European Respiratory Journal|July 19, 2014
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosisMarc A Judson, Robert P Baughman, Ulrich Costabel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I databaseP A Cassier, V Polivka, I Judson, et al.
International Journal of Molecular Medicine|February 6, 2015
BAD-mediated apoptotic pathway is associated with human cancer developmentXiaomang B Stickles, Douglas C Marchion, Elona Bicaku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumorsRuth Plummer, Laura Vidal, Melanie Griffin, et al.
Pageof 234